UPI Mandate for Bids placed between 5 PM and before 10 AM will be received after 10 AM.
Offer Date | May 14 - May 16, 2025 |
Offer Price | ₹ 96-101 |
Lot Size | 1200 |
Please login to Apply IPO
Accretion Pharmaceuticals Limited IPO
NSE SME LiveOffer Date: May 14, 2025 - May 16, 2025
Exp. Premium: 0
₹ 121200 /1200 Shares
Apply*Expected Premium provided in this app is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.
Accretion Pharmaceuticals IPO Live Subscription Details
Date
:16-May-2025 11:58:00 hrs
QIBs
:0.75
NII
:1.54
Retail
:6.07x
Total
:3.64 times
Accretion Pharmaceuticals IPO Details
14 May, 2025
Open Date16 May, 2025
Close Date19 May, 2025
Allotment Date21 May, 2025
Listing DateIssue Price
₹96-101 per equity shareFace Value
₹10 Per Equity ShareListing at Group
NSE SMERegistrar
Kfin Technologies LimitedMarket Lot
1200 Shares (₹121,200/-)Lead Manager
Jawa Capital Services Private LimitedIssue Size
29,46,000 shares(aggregating up to ₹29.75 Cr)Retail Portion
Retail : 45%HNI : 45%
QIB : 5%
Subscription
3.64 times
The IPO of Accretion Pharmaceuticals is priced at ₹96-101 per equity share, which has a face value of ₹10 Per Equity Share each. The company shall list its equity shares on NSE SME. Kfin Technologies Limited is the registrar of the issue.
Accretion Pharmaceuticals IPO bid opening date is from May 14, 2025 and the bid closing date was May 16, 2025.
Accretion Pharmaceuticals IPO allotment result will be available on May 19, 2025. The tentative listing date for Accretion Pharmaceuticals is May 21, 2025.
The total issue size is 29,46,000 shares(aggregating up to ₹29.75 Cr).
Accretion Pharmaceuticals Valuations
EPS Pre IPO
₹4.74/-EPS Post IPO
₹6.28/-P/E Pre IPO
21.29P/E Post IPO
16.08ROE
72.47%ROCE
36.73%Debt/Equity
2.52RoNW
72.47%PAT Margin
11.51Price to Book Value
7.55Accretion Pharmaceuticals Company Financials All values are in ₹ Cr.
| 31-Dec-24 | 31-Mar-24 | 31-Mar-23 | 31-Mar-22 | |
|---|---|---|---|---|
| Assets | 39.99 | 27.05 | 20.58 | 17.74 |
| Revenue | 35.75 | 33.94 | 29.53 | 22.58 |
| Profit After Tax | 5.24 | 3.88 | 0.10 | 0.08 |
| Net Worth | 13.58 | 5.35 | 3.84 | 3.08 |
| Reserves & Surplus | 5.41 | 1.35 | 0.00 | 0.00 |
| Total Borrowing | 13.79 | 13.48 | 8.47 | 7.61 |
About The Company
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical firm that produces and markets tablets, capsules, and other health care products.
The company provides contract manufacturing services as well. The Company produces and sells Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).The company is also certified by ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005, demonstrating its commitment towards quality and environmental management systems.
The manufacturing facility of the company is situated in Ahmedabad, Sanand, Gujarat.The company has spread its wings globally, representing itself in over 20 countries, with locations in Africa, Southeast Asia, as well as the Middle East.
Product Portfolio and Services:
Tablets and Capsules – Encompassing antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal drugs.
Oral Liquids and Syrups – For respiratory, pediatric, and gastrointestinal treatments.
External Preparations – Such as medicated lotions, gels, ointments, and dusting powders for skin treatment and dermatological therapy.
Ayurvedic and Herbal Products – Emphasizing natural wellness remedies for immunity, digestion, and overall health.
As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.
Accretion Pharmaceuticals - Promoter(s)
Pre Issue Share Holding: 100%
Post Issue Share Holding: 73.48%
Company Promoter(s)
- Mr. Mayur Popatlal Sojitra
- Mr. Harshad Nanubhai Rathod
- Mr. Vivek Ashok Kumar Patel
- Mr. Hardik Mukundbhai Prajapati
Accretion Pharmaceuticals IPO - Issue Objectives
- Capital expenditure towards purchase of new equipment/ machineries, etc.
- Capital expenditure towards upgradation of existing manufacturing facility
- Repayment/prepayme nt of certain borrowings availed by the Company
- Funding working capital requirements
- General Corporate Purpose
Other Details
Company Contact Details
Accretion Pharmaceuticals
29 Xcelon Ind Park 1, B/h, Intas Pharmaceuticals, Vasna Chacharvad, Vasna Chacharvadi, Ahmedabad, Sanand, Gujarat,India, 382213Registrar Contact Details
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: apl.ipo@kfintech.com
Accretion Pharmaceuticals IPO - FAQs
Ans. Accretion Pharmaceuticals Limited IPO is a SME IPO. The issue is priced at ₹96-101 per equity share. The minimum order quantity is 1200 Shares. The IPO opens on May 14, 2025, and closes on May 16, 2025. Kfin Technologies Limited is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Ans. The Accretion Pharmaceuticals Limited IPO opens on May 14, 2025 and closes on May 16, 2025.
Ans. The size of Accretion Pharmaceuticals Limited IPO is 29,46,000 shares(aggregating up to ₹29.75 Cr).
Ans. The IPO price band is set between ₹96-101 per equity share.
Ans. To apply for Accretion Pharmaceuticals Limited IPO IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Accretion Pharmaceuticals Limited IPO in the List of IPOs
- - Press "Apply" Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Accretion Pharmaceuticals Limited IPO is May 19, 2025.
Ans. The Accretion Pharmaceuticals Limited IPO will be listed on May 21, 2025.
Ans. Follow the steps to check the allotment status for Accretion Pharmaceuticals Limited IPO here.
